The Place of Whole-Body PET FDG for the Diagnosis of Distant Recurrence of Breast Cancer

This publication has 9 references indexed in Scilit:

• Attenuation correction in whole-body FDG oncological studies: the role of statistical reconstruction.
  European Journal of Nuclear Medicine and Molecular Imaging, 1999
• American Society of Clinical Oncology 1998 Update of Recommended Breast Cancer Surveillance Guidelines
  Journal of Clinical Oncology, 1999
• Value of Combined FDG PET and MR Imaging in the Evaluation of Suspected Recurrent Local-Regional Breast Cancer: Preliminary Experience
  Radiology, 1999
• Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer
  Annals of Surgical Oncology, 1998
• Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging
  European Journal of Surgical Oncology, 1995
• Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer
  British Journal of Surgery, 1994
• Experience with Positron Emission Tomography (PET) Scans in Patients with Ovarian Cancer
  Gynecologic Oncology, 1994
• The Application of Positron Emission Tomographie Imaging With Fluorodeoxyglucose to the Evaluation of Breast Disease
  Annals of Surgery, 1992
• Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.
  Radiology, 1991